Liven Pharma Limited (PSX:LIVEN)
Pakistan · Delayed Price · Currency is PKR 31.48
-0.42 (-1.32%)
At close: Oct 19, 2026
Liven Pharma Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -31.14 | -584.46 | 41.74 | -12.33 | -14.29 |
Depreciation & Amortization | 30.53 | 27.17 | 24.87 | 13.1 | 14.56 |
Other Amortization | 0.31 | 328.27 | 0.69 | - | - |
Loss (Gain) From Sale of Assets | -4.67 | - | - | - | - |
Provision & Write-off of Bad Debts | 11.58 | 116.87 | - | - | - |
Other Operating Activities | 5.95 | 92.62 | 1.15 | -2.9 | -3.22 |
Change in Accounts Receivable | -13.3 | -21.52 | -42.29 | - | - |
Change in Inventory | -6.34 | 0.46 | -11.82 | - | - |
Change in Accounts Payable | 20.64 | 39.4 | 0.21 | - | -0.07 |
Change in Other Net Operating Assets | -4.6 | -0.52 | -0.75 | -0.14 | 0.76 |
Operating Cash Flow | 8.99 | -1.72 | 13.8 | -2.27 | -2.26 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -29.66 | -22.84 | - | - | - |
Sale of Property, Plant & Equipment | 7.15 | - | - | - | - |
Sale (Purchase) of Intangibles | - | -10 | - | - | - |
Investment in Securities | -163.3 | - | - | - | - |
Investing Cash Flow | -185.81 | -32.84 | - | - | - |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 92.42 | 168.72 | 11.34 | 2.27 | 2.24 |
Long-Term Debt Issued | - | 6.68 | 1.36 | - | - |
Total Debt Issued | 92.42 | 175.4 | 12.7 | 2.27 | 2.24 |
Short-Term Debt Repaid | -93.26 | -156.14 | - | - | - |
Long-Term Debt Repaid | -3.28 | -1.8 | -3.54 | - | - |
Lease Payments | -0.7 | -1.36 | -3.54 | - | - |
Total Debt Repaid | -96.53 | -157.94 | -3.54 | - | - |
Net Debt Issued (Repaid) | -4.11 | 17.46 | 9.16 | 2.27 | 2.24 |
Issuance of Common Stock | 200 | - | - | - | - |
Other Financing Activities | -8.7 | - | - | - | - |
Financing Cash Flow | 187.19 | 17.46 | 9.16 | 2.27 | 2.24 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0.03 | - | - | - |
Net Cash Flow | 10.37 | -17.07 | 22.96 | 0 | -0.02 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -20.68 | -24.56 | 13.8 | -2.27 | -2.26 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -19.54% | -19.30% | 5.63% | - | - |
Free Cash Flow Per Share | -0.18 | -0.30 | 345.08 | -0.19 | -0.19 |
Levered Free Cash Flow | 1.32 | 151.56 | -163.82 | 3.45 | 4.31 |
Unlevered Free Cash Flow | 2.85 | 152.02 | -163.81 | 3.45 | 4.31 |
Free Cash Flow After Leases | -21.37 | -25.92 | 10.26 | -2.27 | -2.26 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 2.62 | 0.47 | 0.1 | - | - |
Change in Working Capital | -3.59 | 17.81 | -54.65 | -0.14 | 0.7 |